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COMMENTS
DRUG COURTS AND THE DE FACTO




The recreational possession and use of some drugs is regarded as a
criminal offense in every state in the nation.' What this means for an
offender is that the state views discrete incidents of detected possession not
as manifestations of an over-arching addiction, but as isolated crimes
deserving punishment. This approach comports with a traditional
perception of drug addiction as being explicable as an offender's repeated
and willful refusal to abstain from using drugs.2 If repeated drug use is
* J.D. Candidate, Northwestern University School of Law, 2004. I would like to thank
Professor Susan Provenzano and Professor Len Rubinowitz for their helpful advice and
encouragement.
I See Robert MacCoun & Peter Reuter, Preface: The Varieties of Drug Control at the
Dawn of the Twenty-First Century, 582 ANNALS AM. ACAD. POL. & SOC. SCi. 7, 10-11
(2002). The authors describe a universal cross-national de jure prohibition of recreational
drug possession and use, with the exception of the Netherlands' formal nonprosecution
policy for possession and sale of small amounts of cannabis. They note that "a dozen U.S.
states have decriminalized marijuana possession to some extent," though. Id.
2 Michael C. Dorf & Charles F. Sabel, Drug Treatment Courts and Emergent
Experimentalist Government, 53 VAND. L. REV. 831, 842 (2000) (Prior to the introduction of
drug courts, "the criminal justice system ... saw infractions of the rules of sobriety as a
failure of will that belied the dedication to and capability for recovery (and perhaps
demonstrated criminal intent) .. "); see also DAVID F. MUSTO, THE AMERICAN DISEASE 82-
87, 249 (2d ed. 1987) (describing the long-standing debate among medical practitioners over
whether addiction should be viewed as merely a habit or as a treatable disease).
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interpreted as a result of willful choices, then there is no theoretical
difficulty in punishing isolated uses as separate crimes.3
However, in every state, there is a class of drug users for whom
discrete incidents of use are treated, de facto, not as isolated crimes, but as
part of a treatment process. Some offenders who are charged with a drug-
related crime may be allowed to accept a transfer from criminal trial court
to a drug court,4 some of which are now operational in every state.5 A drug
court is "a court that closely monitors treatment for drug-addicted
defendants brought before it.",6 While under supervision of the drug court,
the offender is placed into a drug treatment program, with the assurance that
charges will be dropped upon successful completion of the program. If a
drug court participant tests positive for drug use while in treatment, the
judicial response is muted. Because relapse to drug use is recognized as an
"expected and accepted" part of the treatment process, the typical drug
court response is not immediate removal to criminal trial court, but a "smart
punishment," which has been described as "not really punishment at all, but
a therapeutic response to the realistic behavior of drug offenders in the grip
3 Cf Powell v. Texas, 392 U.S. 514 (1968). In holding that a fine for public drunkenness
imposed on a man claiming to be a "chronic alcoholic" did not violate the Cruel and Unusual
Punishment Clause of the Eighth Amendment, the Court wrote:
Traditional common-law concepts of personal accountability . . . lead us to disagree with
appellant. We are unable to conclude, on the state of this record or on the current state of
medical knowledge, that chronic alcoholics in general, and Leroy Powell in particular, suffer
from such an irresistible compulsion to drink and to get drunk in public that they are utterly
unable to control their performance of either or both of these acts and thus cannot be deterred at
all from public intoxication.
Id. at 535.
4 Dorf & Sabel, supra note 2, at 832. Note that not every offender who commits a drug-
related crime is eligible for transfer to drug court. See infra notes 64-85 and accompanying
text for a discussion of which drug-using offenders qualify for drug courts. Generally,
requirements include that the offender be considered non-violent and amenable to treatment,
though insufficient funding may preclude all such offenders from enrolling in drug courts.
5 James L. Nolan, Jr., Preface to DRUG COURTS IN THEORY AND IN PRACTICE, at vii-ix
(James L. Nolan, Jr., ed., 2002) [hereinafter DRUG COURTS]. Nolan avers that "by the
summer of 2001, more than 1200 drug courts had been initiated or were in the planning and
implementation stages throughout the United States, with drug courts operating in all fifty
states, the District of Columbia, Guam, and Puerto Rico." Id. at ix. See also OJP DRUG
COURT CLEARINGHOUSE AND TECHNICAL ASSISTANCE PROJECT, AMERICAN UNIVERSITY,
SUMMARY OF DRUG COURT ACTIVITY BY STATE AND COUNTY (2003), available at
http://www.american.edu/justice/publications/drgchart2k.pdf (showing that there are over
one thousand operational, and over four hundred planned, drug courts throughout the
country).
6 Michael C. Dorf, Legal Indeterminacy and Institutional Design, 78 N.Y.U. L. REv. 875,
938 (2003).
7 See Dorf& Sabel, supra note 2, at 832.
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of addiction."8 Sanctions may include more frequent contact with the drug
court, increased urine testing, or short periods of incarceration. 9
The rationale underlying the imposition of these relatively moderate
sanctions is an understanding of drug addiction, not as a sequence of willful
acts, but as a treatable "chronic relapsing condition" which cannot be
managed successfully without missteps along the way.' Drug use is not
viewed as "the failure of treatment, but as an inevitable stumbling block on
the road to abstinence.''"
In its application, the drug court model of addiction as disease works
to create a de facto immunity against further drug-offense prosecution for
drug court participants undergoing residential treatment. Because treatment
facilities do not report on-site drug offenses to the police, but to drug
courts, 12 and because prosecutors will generally not bring new criminal
charges against a drug court participant when treatment facility personnel
report her relapse to the drug court, 3 drug court participants undergoing
residential treatment enjoy a practical immunity from prosecution. The
result of this scheme is that some drug offenders enjoy the benefits of
having their drug use viewed as a treatable disorder, 4 and may emerge from
8 Hon. Peggy Hora et al., Therapeutic Jurisprudence and the Drug Court Treatment
Movement: Revolutionizing the Criminal Justice System's Response to Drug Abuse and
Crime in America, 74 NOTRE DAME L. REv. 439, 469-70 (1998).
9 Richard C. Boldt, Rehabilitative Punishment and the Drug Treatment Court Movement,
76 WASH. U. L.Q. 1206, 1211 (1998).
10 Dorf& Sabel, supra note 2, at 841. Dorf and Sabel elaborate on the adoption of the
"chronic relapsing condition" paradigm:
There was unlikely to be a straight path from addiction to recovery; rather, addicts undertaking
recovery could be expected to relapse into addiction, often many times .... Sanctions were
necessary to demonstrate palpably that relapse was costly, but forbearance was necessary to help
the addict learn through experience to anticipate the conditions that triggered relapse and the
mechanisms for effectively avoiding it.
Id. at 841-42.
1 Hora et al., supra note 8, at 454.
12 Id. at 475; Rehab Staffers Can Reject Queries on Noelle Bush, ST. PETERSBURG TIMES,
Oct. 1, 2002, at 5B ("[O]nly under rare circumstances is law enforcement called in if a
patient is found with drugs [at residential drug treatment facilities]."); Dana Canedy, Judge
Upholds Privacy for Jeb Bush's Daughter, N.Y. TIMES, Oct. 1, 2002, at A22 (relating the
statement of a drug treatment facility's lawyer that, although centers sometimes call police to
retrieve illegal drugs, they do not identify the patient who possessed them, and police
typically do not seek to press new charges against the patient).
13 Hora et al., supra note 8, at 528.
14 Id. at 464 (stating that drug courts view addiction as a biopyschosocial disorder, in that
"biological, psychological, and social factors are deeply woven in the development of
addiction") (quoting John Wallace, Theory of 12-Step-Oriented Treatment, in TREATING
SUBSTANCE ABUSE, 13, 15-19 (Frederick Rogers et al., eds., 1996)).
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a relapse-plagued treatment with a clean record, while other offenders may
be prosecuted for every discrete drug offense under the rationale that drug
use is a willful act that should be curbed through deterrence and
punishment. 
15
The immunity of drug court participants undergoing residential
treatment from criminal prosecution for drug use is only de facto, not de
jure. Drug court statutes typically provide that a drug court judge will
monitor a participant's progression through treatment, returning recalcitrant
offenders to criminal court if necessary.16 They do not, however, explicitly
provide that participants who relapse during treatment will be immune from
prosecution for these new offenses.' 7  Indeed, drug court patients
undergoing outpatient treatment are prosecuted for relapse-related drug
possession.' 8  Instead, participants in residential treatment have three
shields from prosecution. The first two, already mentioned, are
prosecutorial discretion and treatment facility policy.' 9 The third shield,
and the only one that lies in statutory law, is arguably a federal
confidentiality statute, 42 U.S.C. § 290dd-2, which provides that employees
of drug treatment facilities may disclose records concerning treatment
participants only in very limited circumstances.20
The legal status of relapsing drug court participants undergoing
residential treatment is an under-examined facet of drug court
jurisprudence. Since the establishment of the first drug court in Miami,
Florida, in 1989, jurisdictions throughout the nation have enthusiastically
embraced the concept.2' The rapid expansion of a concept that "in many
ways represent[s] a qualitatively new phenomenon in the area of criminal
justice"22 has evoked disparate reactions among commentators, ranging
from gushing praise 23 to unqualified contempt.24  But the empirical fact
15 Dorf & Sabel, supra note 2, at 842 (describing the establishment of drug courts as
marking an abandonment of the view that "deterrence and punishment were the only
effective 'therapies' for drug addiction).
16 See infra notes 106-09 and accompanying text.
17 See infra notes 64-65 and accompanying text.
1s See infra note 110 and accompanying text.
'9 See supra notes 12-13 and accompanying text.
20 42 U.S.C. § 290dd-2 (2002).
21 See infra notes 55-62 and accompanying text.
22 Sara Steen, West Coast Drug Courts: Getting Offenders Morally Involved in the
Criminal Justice Process, in DRUG COURTS, supra note 5, at 51.
23 Hora et al., supra note 8, at 462 (hailing drug courts as "a new approach to breaking
the cycle of drugs and crime").
24 See, e.g., Morris B. Hoffman, The Drug Court Scandal, 78 N.C. L. REv. 1437, 1439
(2000) (describing the rapid spread of drug courts as a "contagion").
[Vol. 94
DRUG COURTS
remains that drug courts have evolved from a single experimental program
into what might be reasonably termed a "movement" 25 in the matter of a
little more than a decade. Because the impetus for this rapid expansion
appears to be more of a response to the structural pressures on local judicial
systems from burgeoning drug-related caseloads 26 and to the strong political
support for the concept 27 than a programmatic implementation of settled
principles, 28 drug courts have achieved the status of a judicial institution
without a thorough examination of their underlying jurisprudence. If drug
courts are to continue to hold a dominant position in American drug policy,
the potential they offer for treating similarly situated drug-using offenders
differently should be examined.
This Comment argues that, because there is currently no legal basis
providing for the immunity of relapsing drug court participants in
residential treatment facilities, states should amend their statutes enabling
drug courts to reflect the practical reality that such participants are immune
from prosecution for drug use during court-supervised treatment. Not only
is immunity for relapse-related use important to the continued vitality and
success of drug courts, but a political recognition that drug courts treat drug
use very differently from the rest of the criminal justice system would
prompt public debate on a policy that is currently being applied sub silentio.
Part I of the Comment examines the rapid, decentralized rise of drug
courts and details their common features, including limited eligibility and
removal of the participant from the criminal justice system. Part II
examines the legal issues presented by the uncertain legal status of drug-
using participants undergoing residential treatment through the lens of
Noelle Bush's recently completed involvement with Florida's drug court
25 Philip Bean, Drug Courts, the Judge, and the Rehabilitative Ideal, in DRUG COURTS,
supra note 5, at 235.
26 Hora et al., supra note 8, at 449 (stating that the focus of early drug court practitioners
was on "preventing the collapse of local court systems under the weight of drug cases").
27 See JAMES L. NOLAN, JR., REINVENTING JUSTICE: THE AMERICAN DRUG COURT
MOVEMENT 53-4 (2001). Noting the "versatile and wide-ranging appeal" of drug courts,
Nolan writes: "Supporters of drug courts span the political spectrum. Conservatives like it
because of its tough, intrusive nature; and liberals like it because of its ostensibly more
humanitarian and rehabilitative qualities." Id.
28 See Hora et al., supra note 8, at 449 ("[F]ew early DTC [drug treatment court]
practitioners worried about the jurisprudential theory behind the DTC movement. DTCs
seemed to work, and the absence of analysis or debate coming from the 'ivory towers' of




system. 29 Part III considers the effect of 42 U.S.C. § 290dd-2 in assuring
confidentiality for individuals undergoing drug treatment in residential
facilities, and concludes that, because the statute cannot be reasonably
interpreted to shield drug court participants from investigation of relapse-
related drug offenses, the continued vitality of drug courts should rest on
stronger, and more transparent, statutory grounds.
I. THE RISE OF DRUG COURTS
Drug courts have spread across the United States through a
decentralized, grassroots process, in which local judges and law
enforcement officials have worked to implement this unique form of
jurisprudence. 30  Each participating jurisdiction has modified, and
experimented with, the drug court model to fit its own needs, yielding a
multiplicity of variations on the basic model. 31 Nevertheless, drug courts in
different jurisdictions share common features, including "relatively
restrictive definition[s] of eligibility ' 32 and a removal of qualifying
participants from the criminal courts and placement into drug court-
supervised treatment. 33 Taken together, these two features ensure that the
29 Noelle Bush is the daughter of Florida Governor Jeb Bush, and the niece of President
George W. Bush. See Peter Wallsten, Noelle Bush Case Sparks Legal Test, MIAMI HERALD,
Sept. 23, 2002, at lB.
30 NOLAN, supra note 27, at 42-43. Nolan cites Louisville drug court judge Henry
Weber, who has stated that the drug court movement is "a grassroots kind of movement. It's
not something where the bureaucrats in Washington tell you what to do. Each community
has developed its own program for its own particular needs and they all deal with it on a
local level .... It's totally a grassroots kind of thing." Id. at 42 (quoting Bean, supra note
25, at 718-21).
31 See John S. Goldkamp, The Drug Court Response: Issues and Implications for Justice
Change, 63 ALB. L. REv. 923,929 (2000). Goldkamp writes:
[T]he original Miami [drug court] model evolved in its successive adaptations in other settings,
and in substance and procedure, was itself transformed as the basic model spread across the
United States and abroad. The drug court methodology has been adapted to grapple with other
problems associated with court populations, including community issues, domestic violence, and
mental health, and has directly and indirectly spawned a variety of related innovations ....
Id.
32 Boldt, supra note 9, at 1209.
13 Id. at 1209-12. These are not the only commonalities across jurisdictions. See
NATIONAL ASSOCIATION OF DRUG COURT PROFESSIONALS, DRUG COURT STANDARDS COMM.,
DEFINING DRUG COURTS: THE KEY COMPONENTS 10 (1997). The National Association of
Drug Court Professionals has identified ten "key components" of drug courts, which are:
integration of treatment and case processing; a non-adversarial approach respecting due
process and public safety; early identification and placement of participants; provision of a
continuum of treatment services; drug testing; court responses to performance in treatment;
monitoring and evaluation; continuing interdisciplinary education; and partnerships between
the court and other criminal justice, health, social services agencies, and the community. Id.
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limited number of drug offenders that qualify for drug courts can receive
very different outcomes in their cases than similar non-qualifying
offenders.34 This part of the Comment traces the rise of drug courts and
describes their common features in more detail.
A. THE SPREAD OF THE DRUG COURT CONCEPT
Drug courts first made their appearance in the late 1980s, against the
backdrop of the "extreme pressures placed on both the judicial process and
local correctional populations" by the increasingly punitive drug policies of
the 19 80 s. As has been often noted, the United States declared a "war on
drugs" in the 1980s, driven at least in part by broad public fears of a
perceived crack cocaine epidemic.36 Throughout the decade, the federal
government and many states "increased public spending on antidrug law
enforcement and dramatically augmented criminal penalties for the sale and
possession of illegal drugs,"37 with the federal government instituting
mandatory minimum sentences for some drug crimes.38 Between 1980 and
1993, American prison and jail populations tripled, much of the increase
due to increased number of drug convictions and longer sentences for drug
offenses.39 By 1994, "drug traffickers (19%) and drug possessors (12.5%)
together made up 31.4% of felons convicted in [s]tate courts, ' '40 and over
half of all federal prisoners were drug offenders.4' Even as law
enforcement efforts intensified and sanctions for drug offenders were made
more severe, publicly-funded treatment became a lower priority.
4 2
The "war on drugs" created special problems for courts. As drug
indictments rose precipitously during the 1980s, responsibility for the cases
34 See Boldt, supra note 9, at 1211 (contrasting drug courts' "array of gradually
increasing penalties" for relapse-related drug use with "the usual all-or-nothing approach
found in most criminal sentencing and parole revocation decisions").
35 Goldkamp, supra note 31, at 945.
36 Boldt, supra note 9, at 1206-07 (stating that the "war on drugs" was "provoked in part
by the emergence of widespread crack cocaine use in a number of large cities and media
accounts of open drug trafficking, gang violence, and rampant property crime").
37 Id. at 1206.
38 Hora et al., supra note 8, at 457.
39 Michael Tonry, Race and the War on Drugs, 1994 U. Cmn. LEGAL F. 25, 25.
40 PATRICK A. LANAGAN & JODI M. BROWN, U.S. DEP'T OF JUSTICE, FELONY SENTENCES
IN STATE COURTS, 1994 (Jan. 1997), quoted in Hora et al., supra note 8, at 460.
41 Hora, et al., supra note 8, at 460.
42 Tonry, supra note 39, at 25. Tonry points to the facts that seventy percent of the
federal funding for drug control was consistently earmarked for law enforcement efforts by
the White House Office of National Drug Control Policy, and that the Office refused to
approve a "treatment on demand" policy despite knowledge that tens of thousands of drug
users wanted to, but could not, gain entry into treatment centers. Id.
2003]
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fell upon courts "already overburdened by high case volumes. 43
Nationally, drug arrests increased 134% between 1980 and 1989,
44
prompting an "almost paralyzing influx of drug cases" that threatened to
"[bring] the court system to its knees by the late 1980s. ''45 Moreover, some
judicial officials were becoming frustrated by the fact that harsher
punishments seemed to cause jail overcrowding while having no effect on
drug offenders' propensity for recidivism.46  As one drug court judge
explained the problem: "Basically, we have had a revolving door
phenomenon where we take an offender, lock him up for whatever
appropriate period of time, and have him back out in the community
without addressing the underlying source of his criminal behavior.
4 7
Drug courts represented a grassroots response to these concerns. The
first drug court was established in Miami, Florida, in 1989, by an
administrative order of the then-Chief Judge of Florida's Eleventh Judicial
Circuit.48 By diverting certain non-violent drug cases 49 into a special court
that would oversee offenders' treatment for drug use, the Circuit hoped both
to relieve crushing caseloads through streamlined procedures and to reduce
recidivism by ameliorating the offenders' drug addictions.50 What began as
a local innovation spread across the country in the same manner, as
individual jurisdictions adopted site-specific adaptations of the Miami
model, supported by locally-generated funding.51
43 Boldt, supra note 9, at 1207.
44 Hora et al., supra note 8, at 459.
45 Id. at 462. See also Goldkamp, supra note 31, at 947 (stating that the large number of
drug cases created an "emergency" in the late 1980s and early 1990s).
46 See NOLAN, supra note 27, at 45-46 ("[T]he institutional realities (e.g., limited prison
space, high rearrest rate among drug offenders, overcrowded court calendars) put pressure on
the judges to come up with other plans for handling this group of offenders."). See Hora et
al., supra note 8, at 461, for a discussion of drug offenders' propensity toward recidivism.
The authors cite a study showing that fifty-one percent of parolees who abuse drugs will end
up in back in prison, compared to a recidivism rate of forty percent for all parolees. Id.
47 NOLAN, supra note 27, at 45. The speaker was Judge Diane Strickland, a Roanoke,
Virginia drug court judge. Id.
48 Hora et al., supra note 8, at 454-55.
49 Hoffman, supra note 24, at 1461.
50 Goldkamp, supra note 31, at 947 ("The theory was not only would potentially large
numbers of drug-abusing defendants be diverted from formal processing and jail, but also by
treating these defendants' substance abuse problems, future returns to the justice system
could be greatly reduced.").
51 Id. at 948 ("The first courts were the product of local innovation and 'elbow grease,'
and, as a rule, produced new initiatives with broad-based support from local justice officials
and with very little, usually locally generated funding.").
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The grassroots spread of drug courts entailed substantial variations in
the implementation of the basic concept throughout different jurisdictions. 2
Drug courts differ in several respects, including the criteria that courts use
to determine participant eligibility, the point in the criminal justice process
when participants are admitted to drug court, and the types of agencies
employed to provide treatment to participants.5 3 Another implication of the
experimental, grassroots spread of drug courts was that they were
implemented without a thorough examination of their jurisprudence and
relation to the traditional criminal justice system. 54
Despite its modest beginnings, the drug court concept has become a
thriving institution in just over a decade.5 By the summer of 2001, there
were over 1100 operational or planned drug courts in the United States, and
an estimated 226,000 offenders had been enrolled in a drug court program.
56
The rapid proliferation of drug courts was spurred by strong political
support at both federal and local levels.57 At the federal level, Congress has
appropriated steadily increasing funding for drug courts since 1994.8 The
52 See NOLAN, supra note 27, at 40. Nolan writes:
Though all the courts follow the essential style and format established in the Dade County
model, each drug court has its own unique features that depend on funding, the level of
community support, personnel and other contingencies. As Phillip Bean puts it, "What one finds
is that there are as many variations in the locus of Drug Courts within the legal system as there
are Drug Courts themselves."
Id. (quoting Bean, supra note 25, at 720).
" See id. at 40-41. For a more detailed discussion of these elements of drug court
jurisprudence, see infra notes 63-110 and accompanying text.
54 Hoffman, supra note 24, at 1440. Hoffman contends that:
[t]he scandal of America's drug courts is that we have rushed headlong into them .... We have
embraced the drug court panacea without asking, let alone resolving, even the most basic of
questions: What is the purpose of drug courts? Do drug courts work? Are the costs of drug
courts, including their costs in de-individualizing justice, worth their benefits?
Id. For a more sympathetic appraisal of the pragmatic motives spurring the rapid
proliferation of drug courts, see supra note 28.
55 See NOLAN, supra note 27, at 39 (relating how "observers" have labeled the "rapid
expansion of the drug court model" as a "movement" or even a "revolution").
56 OJP DRUG COURT CLEARINGHOUSE AND TECHNICAL ASSISTANCE PROJECT, AMERICAN
UNIVERSITY, DRUG COURT ACTIVITY UPDATE: SUMMARY INFORMATION ON ALL PROGRAMS
AND DETAILED INFORMATION ON ADULT DRUG COURTS 1-2 (2001), available at
www.american.edu/academic.depts/spa/justice/publications/allcourtactivity.pdf.
57 NOLAN, supra note 27, at 41-42.
" Hoffman, supra note 24, at 1463 ("In 1994, as part of the amendments to the Omnibus
Crime Control and Safe Street Act of 1968, Congress authorized the attorney general to
make grants and loans to state, local, and Indian tribal governments to establish drug
courts."). Funding dispersed through the Department of Justice's Drug Courts Program
Office increased from twelve million dollars in 1995 to forty million dollars in 1999.
NOLAN, supra note 30, at 42. Although funding has held steady since then, President Bush
20031
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availability of this funding has worked to homogenize drug courts, as newly
proposed drug courts must meet design and implementation criteria set by
the Department of Justice, among them a requirement that drug courts
admit only non-violent offenders, 9 in order to receive funds.
60
State and local governments have also enthusiastically supported drug
courts. 61 A Department of Justice-sponsored study found that twenty-nine
state legislatures had enacted statutes funding drug courts as of May 2001,
with bills pending in eight additional states.62  Many of these statutes
authorize the circuit judges of the state to set up drug courts and proscribe
basic eligibility requirements and procedural formats for the courts to
follow. 63 While these statutes provide a framework for the expansion and
regularization of drug courts within the states, they do not explicitly address
the issue of the legal status of relapsing participants. For example, Illinois's
Drug Court Treatment Act6-which authorizes drug courts to assign
participants to "outpatient, inpatient, residential, or jail-based" treatment
programs-provides that drug courts "shall include a regimen of graduated
requirements and awards and sanctions including . . . fines, fees, costs,
restitution [and] incarceration of up to 180 days" to deal with relapse-
related drug use, but it does not specify that these sanctions preempt the
has requested that sixty-eight million dollars be earmarked for drug courts in 2004. See
NATIONAL ASSOCIATION OF DRUG COURT PROFESSIONALS, ACTION ALERT: ACROSS THE
BOARD BUDGET CUTS REDUCE FUNDINGS FOR DRUG COURTS NATIONWIDE (Feb. 27, 2003), at
www.jointogether.org/sa/news/alerts/reader/0, 1854,5619300,00.html.
59 James J. Chriss, The Drug Court Movement: An Analysis of Tacit Assumptions, in
DRUG COURTS, supra note 5, at 189, 194.
60 Morris B. Hoffman, The Denver Drug Court and Its Unintended Consequences, in
DRUG COURTS, supra note 5, at 67, 81. The criteria can be found in DEFINING DRUG COURTS:
THE KEY COMPONENTS, supra note 33.
6 1 NOLAN, supra note 27, at 42 ("Forty percent of the courts have been at least partially
funded by state support, either through state substance abuse agencies or other state funding
sources. Other jurisdictions have raised money through special tax assessments, asset
forfeiture funds, or fees collected from drunk driving or traffic schools.").
62 OR DRUG COURT CLEARINGHOUSE AND TECHNICAL ASSISTANCE PROJECT, STATUTES
ENACTED IN STATE LEGISLATURES AND TRIBAL COUNCILS RELATING TO DRUG COURTS AS OF
MAY 2001, at 1 (2001), available at www.american.edu/spa/justice/publications/
2001.stat.rev.pdf.
63 See, e.g., FLA. STAT. ch. 397.334 (2003) (directing each judicial circuit to establish, at
the least, a model drug court); FLA. STAT. ch. 948.08 (2003) (outlining basic eligibility
requirements and procedural format); 730 ILL. COMP. STAT. 166/15 (Supp. 2003)
(authorizing the Chief Judge of each judicial circuit to establish a drug court program); 730
ILL. COMP. STAT. 166/20 (Supp. 2003) (outlining eligibility requirements); 730 ILL. COMP.
STAT. 166/25 (Supp. 2003) (describing basic procedural format). See infra note 133 for
citations to additional statutes authorizing the creation of drug courts.
64 730 ILL. COMP. STAT. 166/1 (Supp. 2003).
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standard criminal prohibitions of drug use. 65  The next sub-part of this
Comment, which examines in greater depth the unique rehabilitative
orientation of drug courts, demonstrates how this sanctioning scheme has
allowed drug court participants undergoing treatment in residential facilities
to be treated, sub silentio, under a quite different paradigm of punishment
than offenders punished in the criminal justice system.
B. THE ELEMENTS OF DRUG COURT JURISPRUDENCE
Despite their variations, drug courts across the nation share a common
model. Two important shared elements are limited eligibility and removal




First, eligibility for drug courts is invariably limited to certain groups
of drug-using offenders. 67  The purpose of these limitations is "to insure
that only nonviolent defendants thought to be amenable to substance abuse
treatment participate. 68  To this end, many drug courts screen potential
offenders to ensure that they have a significant substance-abuse problem
and will be suitable candidates for treatment.69 In the Baltimore City Drug
Court, for example, offenders are assessed using the Addiction Severity
Index, which measures medical, employment, drug, alcohol, legal, family,
and psychiatric needs, to determine medical eligibility for treatment.7°
65 Id. 166/25. See also MICH. CoMP. LAWS. § 600.185 (2003) (authorizing fund for the
creation of drug courts, but not addressing how relapsing participants should be treated);
N.Y. CRim. PROC. LAW § 170.15 (McKinney Supp. 2003) (allowing for the removal of cases
from local criminal court to drug court, but not addressing how relapsing participants should
be treated); N.C. GEN. STAT. § 7A-790 to -801 (2001) (establishing state-wide program to
facilitate the creation of drug courts, but not addressing how relapsing participants should be
treated).
66 See supra notes 35-36 and accompanying text.
67 While drug courts predominantly focus on treating offenders charged with drug
possession, drug courts in some jurisdictions also admit drug-using offenders charged with
drug sales, theft, DUI, and prostitution. OJP DRUG COURT CLEARINGHOUSE AND TECHNICAL
ASSISTANCE PROJECT, AMERICAN UNIVERSITY, 2000 DRUG COURT SURVEY REPORT, PART 1:
JUDICIAL PERSPECTIVES [DRAFT] 5 (2001), available at http://www.american.edu/spa/
justice/publications/volI.pdf [hereinafter 2000 DRUG COURT SURVEY REPORT, PART 1].
68 Boldt, supra note 9, at 1209.
69 Chriss, supra note 59, at 194.
70 William D. McColl, Theory and Practice in the Baltimore City Drug Treatment Court,
in DRUG COURTS, supra note 5, at 3, 7.
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Admission criteria also have a public safety aspect, as all drug courts
require that participants have not been charged with a violent offense.7'
Almost all require that participants have no history of violent crimes
whatsoever.72 Some courts also have rigid requirements excluding anyone
with a certain number of prior convictions.73 For example, the Florida
statute enabling drug courts stipulates that participants must not have been
previously convicted of any felony, nor previously admitted to drug court or
a similar felony pretrial intervention program. 74  Other common
disqualifying factors include gang membership, additional pending cases,
and out-of-county residence. 75 As one meta-analysis of drug court studies
concluded, studies suggested that "many drug courts target offenders with
midrange risk levels: higher risk than the low-level offenders typically
given standard diversion [e.g., probation], and lower risk than sentenced
drug offenders.
' 76
In practice, the application of these criteria can result in the exclusion
of a number of offenders who could plausibly benefit from treatment.
Though studies on drug court screening processes are sparse,77 data
suggests that drug courts do not come close to reaching all eligible
offenders. While there were approximately 1,250,000 arrests for drug
possession nationwide in 1999 alone, for example, only about 220,000
individuals had ever been enrolled in an adult drug court through December
2000.78 In a 2000 survey of drug courts, fifty-six percent of the responding
programs indicated that "more people are eligible for the drug court than are
accepted into it."'79 In jurisdictions served by these surveyed drug courts,
there were annual totals of 59,654 felony drug cases and 51,374
71 Boldt, supra note 9, at 1209.
72 2000 DRUG COURT SURVEY REPORT, PART I, supra note 67, at 6.
73 id.
74 FLA. STAT. ch. 948.08 (2003). See also, e.g., 730 ILL. COMP. STAT. 166/20 (Supp.
2003) (outlining Illinois's eligibility requirements, including one that the defendant not have
committed a violent crime in the past ten years).
75 2000 DRUG COURT SURVEY REPORT, PART I, supra note 67, at 7.
76 STEVEN BELENKO, NATIONAL CENTER ON ADDICTION AND SUBSTANCE ABUSE,
COLUMBIA UNIVERSITY, RESEARCH ON DRUG COURTS: A CRITICAL REVIEW, 2001 UPDATE 19
(2001), available at http://www.casacolumbia.org/usr-doc/researchondrug.pdf.
77 Id. at 2 ("A fuller understanding of the impacts of drug courts in the context of the
larger criminal justice system requires more research in the targeting, referral, screening, and
admission process.").
71 Id. at 5-6.
79 2000 DRUG COURT SURVEY REPORT, PART I, supra note 67, at 10. Nearly half of the
rejected eligible offenders were rejected because there were either not enough treatment
services or not enough judicial resources available. Id. at 11.
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misdemeanor drug cases, yet drug courts served only 4104 offenders, or
about 3.7% of combined felony and misdemeanor drug cases. 0
California's experience with drug courts provides a specific example
of drug court under-inclusiveness. One study alleges that "California's
drug courts admit only three to five percent of those offenders who are
eligible for admission into drug court."8' This selectivity may entail
racially discriminatory distinctions being made between eligible offenders,
as another study of four county drug courts demonstrated that the courts
admitted proportionately greater white offenders, "even though persons of
color comprise a disproportionately large percentage of the low-level drug
offender population eligible for drug courts services. 8 2
Insufficient funding and staffing is one factor that compels drug courts
to draw questionably relevant distinctions between candidates. Judge
Morris B. Hoffman, a Colorado state district judge involved in the
development of the Denver Drug Court, relates one example of this
phenomenon.8 3  In 1997, the then-presiding head drug court judge
determined that a twenty-five percent reduction in caseloads was necessary
for the drug court to keep up with filings.8 4 Therefore, he decided to
exclude all two-time felons from drug court.85 As Hoffman writes, "[e]very
two-time felon is not an unacceptable drug court risk," and, indeed, they
had not been viewed as such for the first three years of the drug court's
86existence. Moreover, Hoffman writes, "drug court proponents have long
argued that the hardcore addict"-who is likely to have multiple prior drug-
related convictions-"is precisely the kind of person drug courts were
intended to reach"-the kind of person who is most motivated to make a
lifestyle change. 7 This class of two-time felons, then, was excluded solely
on the basis of inadequate funding. 8 At this point, drug courts have not
80 Id. at 3.
8 DRUG POLICY ALLIANCE, SUBSTANCE ABUSE AND CRIME PREVENTION ACT OF 2000,
PROGRESS REPORT 16 (2002).
82 Id. at 16 n.30 (citing NATIONAL ASSOCIATION OF DRUG COURT PROFESSIONALS, LAW
ENFORCEMENT/DRUG COURT PARTNERSHIPS: POSSIBILITIES AND LIMITATIONS, A CASE STUDY
OF PARTNERSHIPS IN FOUR CALIFORNIA COUNTIES (2000)).
83 Morris B. Hoffman, The Denver Drug Court and its Unintended Consequences, in
DRUG COURTS, supra note 5, at 67.
84 Id. at 73.
85 Id.
86 Id.
87 Id. (citing Steven Belenko, Research on Drug Courts: A Critical Review, in FIRST
NATIONAL DRUG COURT REVIEW 1 (1998)).
88 Id. As Hoffman writes, also referring to the Denver Drug Court's contemporaneous
blanket refusal of illegal aliens, "[T]heir ipso facto exclusion from drug court should make
us all wonder about the fairness of a system that makes these kinds of arbitrary and
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adequately addressed all of the populations that are eligible for, and might
benefit from, treatment.
2. Removal From the Criminal Justice System
A second feature shared by drug courts across jurisdictions is the
removal of participants from the criminal justice system, and placement into
court-supervised treatment.89  Most drug courts operate as "deferred
prosecution" or "postdisposition" programs.90  In deferred prosecution
programs, courts evaluate offenders for drug court eligibility soon after
their arrest, and stay all charges against accepted participants. 9' If a
participant successfully completes the treatment program, the charges are
dropped.92 Postdisposition programs require that participants enter a guilty
plea prior to transfer to the drug court, but, as in deferred prosecution
programs, criminal punishment is withheld if the participant successfully
completes treatment.93
Offenders enter court-supervised treatment upon enrollment in a drug
court program.94  The goal is to facilitate drug abstinence through
treatment,95 using the threat of expulsion from the program and concomitant
adjudication of the original charge in criminal court to compel
cooperation. 96 Participants are generally expected to undertake treatment
for at least one year, but treatment "often lasts much longer," depending on
the participant's progress.97 Local treatment providers directly supervise
participants,98 and the types and content of treatment services offered by the
suspicious distinctions simply because drug court proponents have bitten off more than they
can chew." Id.
89 See Boldt, supra note 9, at 1255.
90 Id. Boldt cites a study concluding that forty-four percent of drug courts work on the
deferred prosecution model, and thirty-eight percent work on a postdisposition model. Id. at
1255 n.283.
9' Id. at 1255.
92 id.
9' Id. at 1255 n.283.
94 Hora et al., supra note 8, at 463 ("Now identified as 'Drug Treatment Courts,' this
system of court-prompted and supervised treatment for drug offenders aims at correcting the
addictive behavior of the drug offenders who enter the courts.").
95 John Terence A. Rosenthal, Therapeutic Jurisprudence and Drug Treatment Courts, in
DRUG CouRTs, supra note 5, at 144, 161.
96 Hora et al., supra note 8, at 527 ("What DTCs [drug treatment courts] provide to the
drug abuser is a legal incentive to stay in drug treatment.").
97 NOLAN, supra note 27, at 40.
98 See Hora et al., supra note 8, at 480.
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program differ across jurisdictions.9 9 While there do not appear to be any
studies indicating the percentage of participants who undergo residential
treatment, a 2000 survey of drug courts indicated that at least some
participants were offered short-term treatment (up to thirty days) in over
fifty percent of surveyed programs, and long-term treatment (ranging from
thirty to more than ninety days) in roughly forty percent of surveyed
programs.l°°
After a participant's case is transferred to a drug court, the drug court
judge assumes broad supervision over the case and is viewed as an integral
part of the treatment process. 10 ' Drug court judges monitor the progress of
participants by keeping tabs on the results of frequent drug tests;1
0 2
participants are also required to make weekly, bi-weekly, or monthly group
appearances before the drug court judge.10 3 During these appearances, drug
court judges act "more like proactive therapists than dispassionate judicial
officers"; 0 4 judges alternately praise, cajole, and reprimand participants in
order to encourage compliance with the treatment process. 0 5
Drug court judges hold participants responsible for continued drug use,
stalled progression in treatment, or failure to make mandatory appearances
through the use of "smart punishments," or intermediate sanctions.10 6 In
99 Goldkamp, supra note 31, at 938. The array of treatment services includes outpatient
group therapy, outpatient individual therapy, acupuncture, relapse prevention, and short-term
and long-term residential treatment. See OJP DRUG COURT CLEARINGHOUSE AND TECHNICAL
ASSISTANCE PROJECT, AMERICAN UNIVERSITY, 2000 DRUG COURT SURVEY REPORT, PART
VII: TREATMENT PROVIDER PERSPECTIVES [DRAFT] 11 (2001), available at
http://www.american.edu/spa/justice/publications/volIV.pdf.
100 2000 DRUG COURT SURVEY REPORT, PART VII: TREATMENT PROVIDER PERSPECTIVES
[DRAFT], supra note 99, at 11.
101 See Hoffman, supra note 24, at 1517 ("[Tlhe whole drug court mechanism
depends... heavily on the philosophy of the particular judge who is presiding there at any
time .... "). Hoffman contrasts the very different philosophies of two judges in the Denver
Drug Court regarding the imposition of intermediate sanctions upon relapsing participants.
Id. at 1517-18.
102 Hora et al., supra note 8, at 475.
103 NOLAN, supra note 27, at 40.
104 Id.
105 Id. at 71. As Judge Langston Kinney, a drug court judge in Syracuse, New York
described the process:
In reality, for the benefit of the people in the gallery, drug court is like a theatre, it's judicial
theatre .... We pat some people on the back, we slap some people on the rump. We hug some
people, literally, and some people we chastise. But it's all for the purpose of making sure that
everybody who is here has some understanding that the purpose is all the same.
Id.
106 Hora et al., supra note 8, at 475, 509-10. For examples of smart punishment, see
supra note 9 and accompanying text.
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line with the drug court's rehabilitative orientation, these sanctions are not
intended to punish participants for moral failure, but to "underscore the
therapeutic perspective and goal of the [drug court] concept."'10 7 Offenders
are removed only rarely from drug court programs, after continued drug use
does not respond to escalating sanctions.0 8 The smart punishment regime
demands that prosecutors not file additional charges based on drug use
revealed through the drug court monitoring process. 1° 9
Drug court participants are not completely immune from prosecution
on new drug charges. If a participant is re-arrested during treatment, he
may be prosecuted for the new crime.1 0 In the case of participants
undergoing residential treatment, though, arrest for relapse-related drug use
is not a likely outcome, given that treatment facilities report relapse-related
drug use and possession to drug courts, and not to the police."' The
experience of the Miami Drug Court provides striking, if anecdotal,
evidence of what can happen without sufficient judicial or law enforcement
oversight of treatment providers. 12 In 1994, state prosecutors concluded a
two-year investigation of drug court-approved halfway houses, having
determined that prostitution and narcotics trafficking were taking place in
the facilities; prosecutors lacked sufficient evidence to bring any charges,
though. 13 Because of the combined effect of drug courts' rehabilitative
orientation and treatment facility control over police notification, drug court
participants undergoing residential treatment are, for all practical purposes,
insulated from prosecution for relapse-related drug use.
107 Hora et al., supra note 8, at 470. ("Smart punishment by [drug courts] means 'the
imposition of the minimum amount of punishment necessary to achieve the twin sentencing
goals of reduced criminality and drug use."') (quoting JUDGE JEFFREY S. TAUBER,
CALIFORNIA CENTER FOR JUDICIAL EDUCATION AND RESEARCH, DRUG COURTS: A JUDICIAL
MANUAL 9 (1994)).
'0o Id. at 484.
'09 See id. at 478-79. The authors suggest that prosecutors should be amenable to this
arrangement because, "[b]y understanding the nature of addiction and treatment, a
prosecutor comes to realize that the therapeutic jurisprudence approach taken by a [drug
court] reflects nothing more than the realization that the court process itself can and does
impact the behavior of a defendant." Id. at 479.
1o 2000 DRUG COURT SURVEY REPORT, PART I, supra note 67, at 35.
111 See supra notes 12-13 and accompanying text.
112 See Hora et al., supra note 8, at 524.
113 Id. (citing Jeff Leen & Don Van Natta Jr., Drug Court Favored By Felons, MIAMI
HERALD, Aug. 29, 1994, at 6A).
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II. THE NOELLE BUSH CASE: THE PROBLEMS CREATED BY THE UNCERTAIN
STATUS OF RELAPSING DRUG COURT PARTICIPANTS UNDERGOING
RESIDENTIAL TREATMENT
The de facto immunity of drug court participants undergoing
residential treatment, and its doubtful legal status, was brought into sharp
focus in 2002 by the case of Noelle Bush, who was arrested in Florida on a
charge of prescription fraud.114 Bush was admitted to an Orange County
drug court, and entered a residential treatment center." 5 She apparently
relapsed on multiple occasions while undergoing treatment and, on one
occasion, a fellow patient notified police that Bush had been caught with
crack cocaine." 6 When police attempted to investigate, the treatment center
employee who witnessed Bush's drug possession refused to cooperate. 1 7
The state's attorney moved to compel the employee's testimony, but
Florida's Ninth Judicial Circuit denied the motion." 8 The court relied
solely on 42 U.S.C. § 290dd-2, a statute designed to ensure the privacy of
drug treatment participants,1 9 in holding that treatment facility employees
were permitted, but could not be compelled, to notify police of crimes
occurring on facility property.120 This part of the Comment examines the
facts of Bush's case and the circuit court's reasoning in holding that drug
court participants undergoing residential treatment are legally insulated
from criminal prosecution of their relapse-related drug use.12
A. BUSH'S LEGAL TRAVAILS
During the early morning of January 29, 2002, Noelle Bush was
arrested in Tallahassee, Florida, after attempting to fill a fraudulent
prescription for the sedative Xanax at a drive-through pharmacy window.,2 2
Bush allegedly had called the pharmacy herself, posing as a "Dr. Noelle
Scidmore," to order the prescription.1 3 Pharmacists grew suspicious after
114 See infra notes 122-27 and accompanying text.
115 See infra notes 128-34 and accompanying text.
116 See infra notes 135-36, 140-41 and accompanying text.
117 See infra notes 142-45 and accompanying text.
118 See infra notes 177-90 and accompanying text.
119 See infra notes 177-90 and accompanying text.
120 See infra notes 177-90 and accompanying text.
121 The State of Florida attempted to appeal the Ninth Judicial Circuit's decision to
Florida's Fifth District Court of Appeals. That court denied the State's petition for certiorari
on Mar. 7, 2003 and issued a brief opinion. The reasoning underlying the opinion is
discussed below. See infra note 190.
122 Deborah Sharp, Jeb Bush's Daughter Arrested on Prescription Fraud Charge, USA




they determined that no such doctor presently practiced in Tallahassee, and
notified police.1 24 The crime with which Bush was charged, prescription
fraud, is a felony of the third-degree under Florida law, 125 punishable by a
maximum imprisonment of five years and a $5,000 fine.126 Bush had no
known prior criminal record.1
27
As a first-time, non-violent offender, Bush was eligible for
participation in one of Florida's pretrial substance abuse education and
treatment intervention programs, more commonly known as a drug court.
28
If the defendant successfully completes treatment, the court will dismiss the
original charges; if treatment is not successful, the drug court judge will
return the defendant's case to criminal trial court for prosecution of the
original charge. 29  As is typical of other state legislatures, the Florida
legislature has authorized, but not required, circuit courts to establish drug
courts in their jurisdictions. 3 0 In addition, Florida circuit courts maintain
discretion in determining which qualifying offenders will be admitted to
drug court. 3 ' Though the offender, the State, or the court itself may file a
124 Id.
125 FLA. STAT. ch. 893.13(7)(a)(9), (7)(c) (2002). Section 893.13(7)(a)(9) makes it illegal
"[t]o acquire or obtain, or attempt to acquire or obtain, possession of a controlled substance
by misrepresentation, fraud, forgery, deception, or subterfuge," and (7)(c) specifies that this
crime is a felony of the third degree.
126 Id. ch. 775.082-775.083.
127 Sharp, supra note 122, at 5A.
128 See FLA. STAT. ch. 948.08(6)(a) for the statutory requirements for admission into a
Florida drug court program for felony drug offenders. In addition to limiting eligibility to
non-violent offenders without a prior felony conviction, the statute also precludes
participation by offenders who have been involved in the dealing or selling of controlled
substances.
129 Id. ch. 948.08(3)-(5).
130 See id. ch. 948.08(6)(a). The statute authorizes qualifying felony offenders to enter
into a "pretrial substance abuse education and treatment intervention program approved by
the chief judge of the circuit," but does not require the chief judge of the circuit to approve
any such program. The Florida legislature has passed a statute expressing the intent "to
implement treatment-based drug court programs in each judicial circuit," though. Id. ch.
397.334 (2002). See also 730 ILL. COMP. STAT. 166/15 (Supp. 2003) (authorizing the Chief
Judge of each judicial circuit to establish a drug court program); N.Y. CRiM. PROC. LAW §
170.15 (McKinney Supp. 2003) (allowing for removal of case from a local criminal court to
a "court in the same county which has been designated a drug court by the chief
administrator of the courts"); N.C. GEN. STAT. § 7A-790-801 (2001) (setting up state
program to facilitate the creation of drug courts, but not requiring the same); WASH. REV.
CODE ANN. § 2.28.170 (West Supp. 2003) ("Counties may establish and operate drug
courts.") (emphasis added).
13 FLA. STAT. ch. 948.08(6)(a).
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motion to place the offender in drug court, the court must approve the
motion. 132
Bush opted for participation in drug court. Her case was transferred
from Leon to Orange County, where she entered into treatment at the
Center for Drug-Free Living, a residential drug treatment facility, soon after
her arrest.133 She then entered into drug court supervision in June.1 34 Bush
was progressing satisfactorily through treatment and tested negative for
drug use for five months, until July, when an employee of the Center for
Drug-Free Living found her in unauthorized possession of prescription
pills.1 35 The dfug court judge supervising Bush's case was notified of
Bush's indiscretion and sentenced her to two days in jail for violation of her
treatment terms.
136
As discussed above, the revelation of Bush's relapse only in drug court
is a typical outcome for relapsing drug court participants undergoing
residential treatment. 37  Under the typical drug court regime, drug
treatment officials release information regarding participant relapse only in
the drug court setting, when they provide the drug court judge, prosecutor,
and defense counsel with reports on the participant's progress.'38 The
Center for Drug-Free Living's policy, for example, is for staff members to
call police when illegal drugs are found on the premises, but only to ask for
advice in disposing of the drugs; staff members are not to reveal the identity
of the patient possessing the drugs. 
139
After her release from jail, Bush returned to the Center for Drug-Free
Living, and apparently avoided relapse again until September, when an
employee allegedly found a small rock of crack cocaine in Bush's shoe.140
Unlike the consequences that attended her previous relapse, the typical drug
court protocol was short-circuited on this occasion when Orlando police
became involved. After Bush was caught, a fellow patient at the Center for
132 id.
33 See Order Denying Motion to Close Drug Court Proceedings at 2, Florida v. Bush,
No. 48-02-CF-6371-0 (Fla. Cir. Ct. Oct. 22, 2002), available at http://www.ninja9.org;
Drug Facility Staff May Remain Silent on Noelle Bush, WASH. POST, Oct. 1, 2002, at A02
[hereinafter Drug Facility Staff May Remain Silent].
134 Order Denying Motion to Close Drug Court Proceedings at 2, Bush (No. 48-02-CF-
6371-0).
135 Wallsten, supra note 29, at lB.
136 id.
137 See supra note 12-13 and accompanying text.
138 See Hora et al., supra note 8, at 528; see also supra notes 15-16 and accompanying
text.




Drug-Free Living called the police, related the alleged incident, and stated
that Bush had been caught with drugs on previous occasions and gone
unpunished.1 41 Orlando police arrived at the Center to investigate the report
and talked to a staff member who confirmed that Bush had been caught
with cocaine. 4  The employee who had found the cocaine initially offered
a sworn written statement, but she tore it up at the behest of her
supervisor. 1
43
The Orange-Osceola County State's Attorney's Office quickly issued
investigative subpoenas to four Center employees and deposed one of
them. 44  During the deposition, the employee refused to answer any
questions about Bush's alleged possession.145 The state then filed a motion
to compel the clinic employee's testimony. 146 The state's attorney argued
that the state, acting through law enforcement officials, had the
responsibility to investigate all reports of criminal activity, and that a denial
of its motion would be tantamount to granting participants in residential
substance abuse treatment facilities blanket immunity from being charged
with drug offenses. 47 In its defense, the Center relied solely upon a federal
statute, 42 U.S.C. § 290dd-2,148 designed to protect the privacy of
individuals undergoing treatment for substance abuse at federally funded
treatment facilities. 49  According to the Center's interpretation of the
statute, the records of a patient at such a facility may not be released to
initiate or substantiate a criminal charge against the patient unless the
release is authorized by a court order, which is to be issued on the showing
of good cause. 5 °
'41 Id. The caller stated:
She does this all the time and she gets out of it because she's the governor's daughter .... But
we're sick of it here 'cause we have to do what's right, but she gets treated like some kind of
princess. We're just trying to get our lives together, and this girl's bringing drugs on property.
Id.
142 id.
14' Drug Facility Staff May Remain Silent, supra note 133, at A02.
144 Order Denying Motion to Compel at 1, In re Investigation, Orlando Police
Department, Case No. 2002-330145 (Fla. 9th Cir. Ct. Sept. 30, 2002) [hereinafter Order
Denying Motion to Compel], available at www.ninja9.org.
145 Id.
146 Id. at 1-2.
141 Id. at 9.
14' 42 U.S.C. § 290dd-2 (2000).
149 Order Denying Motion to Compel, supra note 144, at 3.
So Id. at 5-6.
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B. SECTION 290DD-2'S PROVISIONS
The details of § 290dd-2 are relatively complex and merit a close
analysis. The confidentiality provisions now embodied in 42 U.S.C. §
290dd-2 were originally passed in 1972, in the wake of the Comprehensive
Drug Abuse Prevention and Control Act of 1970, which, though it
established a comprehensive policy for enforcement of federal drug laws,
also provided for increased expenditures on rehabilitation and treatment
efforts.'
The legislative history for the bill by which the confidentiality
provisions were passed, the Drug Abuse Office and Treatment Act of
1972,152 indicates that Congress had maintained its orientation toward
rehabilitative programs, as this summary of testimony demonstrates:
"Taking into account that the law enforcement aspects of the drug problem
are serious, most witnesses generally agreed that greater emphasis on the
so-called 'demand side' of the problem is required, that is, on treatment,
rehabilitation, research, education and training."'
153
Statutory provisions establishing the confidentiality of records on
participants in federally funded drug treatment centers were regarded as part
of the scheme to facilitate demand reduction, because, as the legislative
history indicates, they were passed in response to concerns that drug users
would not seek treatment if they could not be assured of privacy. 54 The
House Report is adamant that the confidentiality requirements are to be
followed, expressing the conviction that "the strictest adherence to the
... See H.R. REP. No. 91-1444, pt. 1, at 1-3 (1970). The legislative history also revealed
a broad intent to treat offenders on a rehabilitative model:
If the [drug] abuser is to be penalized, he should not be punished in the spirit of retribution. The
modem concept of criminology should apply--that penalties fit offenders as well as offenses.
Penalties should be designed to permit the offender's rehabilitation wherever possible ....
The deterrent effects of long sentences is debated. Some evidence indicates that the threat of
long sentences may deter nonusing traffickers, but it does not necessarily deter the drug abuser.
Deterrence is essentially an appeal to a normal sense of reason which the drug abuser has lost.
Id. at 9.
t Pub. L. No. 92-275, 86 Stat. 65 (1972).
s H.R. REP. No. 92-775, at 4 (1972).
154 Id. at 6.
Every patient and former patient must be assured that his right to privacy will be protected.
Without that assurance, fear of public disclosure of drug abuse or of records that will attach for
life will discourage thousands from seeking the treatment they must have if this tragic national
problem is to be overcome.
2003]
ANDREWARMSTRONG
provisions of this section is absolutely essential to the success of all drug
abuse prevention programs."' 
55
The statute allows for the release of patient records only under narrow
circumstances. Section 290dd-2(a) stipulates that patient records may be
disclosed only in the circumstances identified in § 290dd-2(b). 15 6 Section
290dd-2(b) provides only four valid methods of disclosure. First, a patient
may consent to the release of her records.'57 Second, the holder of a record
may disclose its contents to medical personnel in the event of an
emergency. 5 8  Third, records may be disclosed for the purpose of
conducting research, but any report of such research must not disclose the
identity of any patient. 5 9 Finally, a court of competent jurisdiction may
order the release of a record, on a showing of good cause, "including the
need to avert a substantial risk of death or serious bodily harm."'160  The
statute commands that, in assessing good cause, a court "shall weigh the
public interest and the need for disclosure against the injury to the patient,
to the physician-patient relationship, and to the treatment services.' 161
Section 290dd-2(c) indicates that only records released by the fourth
method, issuance of a court order, may be used to conduct a criminal
investigation against a patient.
62
The Department of Health and Human Services regulations
implementing the confidentiality provisions are found at 42 C.F.R. § 2.1-
2.67.163 An important point to note initially is that the regulations never
require disclosure of patient records. As § 2.3(b) explains, "These
regulations prohibit the disclosure and use of patient records unless certain
circumstances exist. If any circumstances exists under which disclosure is
permitted, that circumstance acts to remove the prohibition on disclosure
155 id.
16 42 U.S.C. § 290dd-2(a) (2000). The statute extends to
[r]ecords of the identity, diagnosis, prognosis, or treatment of any patient which are maintained
in connection with the performance of any program or activity relating to substance abuse
education, prevention, training, treatment, rehabilitation, or research, which is conducted,
regulated, or directly or indirectly assisted by any department or agency of the United States ....
Id.
157 Id. § 290dd-2(b)(1).
"' Id. § 290dd-2(b)(2)(A).
'9 Id. § 290dd-2(b)(2)(B).
160 Id. § 290dd-2(b)(2)(C).
161 Id.
162 Id. § 290dd-2(c) ("Except as authorized by a court order granted under subsection
(b)(2)(C) of this section, no record referred to in subsection (a) of this section may be used to
initiate or substantiate any criminal charges against a patient or to conduct any investigation
of a patient.").
163 42 C.F.R. § 2.1-2.67 (2002).
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but it does not compel disclosure. Thus, the regulations do not require
disclosure under any circumstances.' 64
The regulations also clarify aspects of the definition of "records of the
identity, diagnosis, prognosis, or treatment of any patient," as used in 42
U.S.C. § 290dd-2, and of the good cause requirement. "Records" is defined
in the regulations' definitions section, § 2.11, as "any information, whether
recorded or not, relating to a patient received or acquired by a federally
assisted alcohol or drug program."'' 65 "Treatment" is defined as meaning
"the management and care of a patient suffering from alcohol or drug
abuse, a condition which is identified as having been caused by that abuse,
or both, in order to reduce or eliminate the adverse effects upon the
patient.'1 66 "Records" of the diagnosis and treatment of a patient would
seem, then, to encompass any information, whether recorded or not, that
was received or acquired by a federally assisted alcohol or drug program,
and that related to the management and care of that patient.
Section 2.65 contains more detail on the good cause determination
required to order disclosure of records that are to be used to criminally
investigate or prosecute a patient. 167 The regulation specifies five criteria
that must be met for a court to authorize the release of a record, two of
which are relevant in Bush's case. First, the regulation specifies that the
crime to be investigated must be "extremely serious, such as one which
causes or directly threatens loss of life or serious bodily injury including
homicide, rape, kidnapping, armed robbery, assault with a deadly weapon,
and child abuse and neglect.', 168  Second, the regulation restates the
balancing test articulated in 42 U.S.C. § 290dd-2(b)(2)(C), requiring that
"the potential injury to the patient, to the physician-patient relationship and
to the ability of the program to provide services to other patients is
outweighed by the public interest and the need for the disclosure.',
169
Section 2.65's requirement that the crime involved be "extremely
serious, such as" one mentioned in the subsequent list, deserves special
notice in the context of drug possession cases because of a 1987
amendment of that requirement. 70 The original regulation required only
164 Id. § 2.3(b).
165 Id. § 2.11.
166 id.
167 Id. § 2.65. See 42 U.S.C. § 290-dd-2(b)(2)(C) for the good cause requirement.
168 42 C.F.R. § 2.65(d)(1).
169 Id. § 2.65(d)(4). The other three criteria concern the importance and necessity of the
information to the investigation and the adequacy of counsel for the holder of the records.
170 See Confidentiality of Alcohol and Drug Abuse Patient Records, 52 Fed. Reg. 21,796,
21,802 (June 9, 1987).
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that a crime be "extremely serious."'' In order to provide a better guide for
courts, the agency added the "one which causes or directly threatens loss of
life or serious bodily injury" clause and the examples of crimes that fit that
definition. 172 "[S]ale of illicit drugs," was proposed for the list of examples,
but that crime was removed when many commentators charged that
including the crime "would make almost all patients in drug rehabilitation
or treatment programs vulnerable to investigation or prosecution by means
of court-ordered use of their own treatment records."'' 73 In the Federal
Register, though, the agency asserted that the absence of "sale of illicit
drugs" from the list did not preclude courts from determining that, in a
given circumstance, sale of illicit drugs qualified as an "extremely serious"
crime. 74
Finally, the enabling regulations also include an exception to
confidentiality requirements that is highly relevant to Noelle Bush's case.
Section 2.12(c)(5) states:
The restrictions on disclosure and use in these regulations do not apply to
communications from program personnel to law enforcement officers which ... [a]re
directly related to a patient's commission of a crime on the premises of the program
or against program personnel or to a threat to commit such a crime ....
175
Such communications must be "limited to the circumstances of the incident,
including the patient status of the individual committing or threatening to
commit the crime, that individual's name and address, and that individual's
last known whereabouts.',
176
As the discussion in the next two sub-sections will demonstrate, this
regulatory exception sits uncomfortably with § 290dd-2(c)'s requirement
that information about a crime on program premises cannot be disclosed
without a court order issued pursuant to a showing of good cause.
C. THE NINTH JUDICIAL CIRCUIT COURT'S APPLICATION OF § 290-DD2
Florida's Ninth Judicial Circuit Court applied § 290dd-2 in denying
the state's motion to compel the testimony of the employee of the Center
for Drug-Free Living who observed Bush's alleged possession of cocaine,
in an opinion issued on September 30, 2002.177 The court began its opinion





7' 42 C.F.R. § 2.12 (c)(5), (c)(5)(i) (2002) (emphasis added).
176 Id. § 2.12 (c)(5)(ii).
177 Order Denying Motion to Compel, supra note 144, at 1, 5-9.
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clash between important public policy interests: the state law enforcement
and prosecutorial agencies' duty to investigate crime, versus the state
Legislature's intention to address the serious social problem of drug abuse
and addiction through programs outside of the criminal justice system.', 7
The court then turned its attention to § 290dd-2, noting that the purpose of
the statute was "to encourage people to get help for addictions" by assuring
them that their privacy would be as protected as it would have been had
they not sought treatment.
1 79
The court first dealt with § 2.12's exception to confidentiality
requirements for "communications from program personnel to law
enforcement officers which . . . [a]re directly related to a patient's
commission of a crime on the premises of the program or against program
personnel or to a threat to commit such a crime .... ,18o The State argued
that "the issuance of an investigative subpoena is enough to enable Center
employees to divulge to law enforcement personnel what they observed of
alleged crimes committed on the premises, without fear of penalties.',
81
While the court agreed that the purpose of § 2.12(c) was to enable treatment
facility employees to relate information regarding patient crimes to law
enforcement officials without suffering legal penalty, it concluded that
neither the regulation nor the State's issuance of an investigative subpoena
created a duty for employees to reveal such information.
82
17s Id.
179 Id. See also 42 C.F.R. § 2.3(b)(2) (2002).
[These regulations] are intended to insure that an alcohol or drug abuse patient in a federally
assisted alcohol or drug abuse program is not made more vulnerable by reason of the availability
of his or her patient record than an individual who has an alcohol or drug problem and who does
not seek treatment.
Id.
"0 42 C.F.R. § 2.12(c)(5), (c)(5)(i) (2002).
s18 Order Denying Motion to Compel, supra note 144, at 6 (emphasis in original).
Having defined "records" as including "patient identities, diagnoses, treatment plans, and
progress reports," the court did not address the issue of whether the non-cooperative
employee's unmemorialized personal observations of a patient's criminal actions were
records under § 290dd-2, though it implicitly held that they were, given that the court found
the statute applicable. Id. at n.2.
182 Id. at 8.
Since the federal statute provides for penalties to be imposed against treatment centers if they
make impermissible disclosures, it is evident that Regulation 2.12 is designed to allow a facility
to report to the police that a non-drug-related crime has been committed on its premises without
fear of being penalized for violating patient confidentiality. It is certainly not intended to compel
center employees to talk to police officers.
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Instead, the court held that, even in a case where a patient had
committed a crime at the facility, and a treatment facility employee could
legally volunteer to report information about the crime to law enforcement
officials, the State must abide by the requirements of § 290dd-2(b)(2)(C)
and 2(c) when trying to obtain information from a non-cooperative
treatment facility employee. 183  Because §290dd-2(c) requires that only
information released through court order may be used in conducting a
criminal investigation of a patient, the court concluded, the State would
have to demonstrate good cause for the court to compel the testimony of the
non-cooperative employee. 
84
The court held that the State had not shown good cause for the
issuance of a court order to compel the testimony.1ss The court, as
commanded by § 290dd-2(b)(2)(C), weighed "the public interest and the
need for disclosure against the injury to the patient, to the physician-patient
relationship, and to the treatment services. ' 86 In weighing these competing
interests, the court drew a distinction between crimes involving illegal
drugs and other crimes, and explained that to allow the release of drug
treatment facility records regarding patient relapse would undermine
Florida's drug court program by "thwart[ing] the Legislature's purpose to
make the drug court the entity that monitors a person's treatment progress
and determines whether he or she has successfully completed the
program. 1 87 The court described the drug court system as an alternative to
the criminal justice system, wherein relapse is expected, and taken into
consideration when assessing a participant's progress. 88  The court
dismissed the State's argument that denying a motion to compel testimony
would amount to a blanket license to commit drug crimes by describing it
as "based on the misguided notion that each incident of drug possession
constitutes a new crime, unrelated to the patient's presence in the
18 id.
The State's argument that an investigative subpoena is all that is needed is belied by 42 U.S.C. §
290dd-2.(c), which clearly states that only a court order may compel such testimony. It takes a
court order issued pursuant to § 290dd-2.(b)(2)(C) before drug clinic employees may be ordered
to disclose patient information to police pursuant to Regulation 2.12.
Id.
184 Id. ("[A] court order will not issue unless State shows good cause and the Court finds
that the balancing test of § 290dd-2(b)(2)(C) favors police investigation under the
circumstances of the particular case.").
85 Id. at 8-10.
's 42 U.S.C. § 290dd-2(b)(2)(C) (2000).




program."' 89 The State Attorney's Office attempted to appeal the decision
to Florida's Fifth Circuit Court of Appeals, but its petition for review was
denied on March 7, 2003.190
III. CONFIDENTIALITY, IMMUNITY, AND THE CONTINUED VITALITY OF
DRUG COURTS
The Ninth Judicial Circuit's denial of the State's motion to compel the
testimony of the non-cooperative Center employee raises two issues. The
first is whether the court correctly interpreted § 290dd-2 and its enabling
regulations, which are the only conceivable nationwide19' legal bases for the
de facto immunity of drug court participants undergoing residential
treatment. The court's holding that, although § 2.12(c) permits record
holders to voluntarily release records related to a patient's commission of a
crime on treatment program premises, a state's attorney attempting to
obtain such records must obtain a court order pursuant to § 290dd-
2(b)(2)(C), is suspect. The court's reading of § 2.12(c)'s requirement that
the information be in the form of a communication "from program
personnel to law enforcement officers" as denoting an intent that the
regulation concerns only communications initiated by program personnel is
unduly restrictive.19 2  The regulation is more reasonably construed as
applying to all communications regarding patient crimes, regardless of the
party that motivates the disclosure. The court should have found that §
290dd-2 did not shield the Center for Drug-Free Living from the state's
motion to compel.
189 Id. at 9.
90 See Petition for Certiorari Review of Order, Florida v. Center For Drug-Free Living,
No. 5D02-3356 (Fla. 5th Dist. Ct. App. Mar. 7, 2003), available at
http://www.5dca.org/Opinions/Opin2003/030303/5DO2-3356.op.pdf. The district court of
appeals agreed with the circuit court's reading of the regulatory exemption for information
regarding crimes committed on facility property to pertain only to communications initiated
by facility employees. Id. at 7. The court also agreed that a court order allowing disclosure
of the witnessing employee's observations should not issue because disclosure would
discourage addicts from seeking out treatment and would hobble the drug court system. See
id. at 4, 7-8.
191 The qualifying term "nationwide" is necessary, because some states have enacted
drug treatment confidentiality statutes that differ from § 290dd-2, and may provide
independent bases for challenging the release of information to law enforcement officials.
See NAT'L DRUG COURT INST., FEDERAL CONFIDENTIALITY LAWS AND How THEY AFFECT
DRUG COURT PRACTITIONERS 4 (1999) (noting that, while some states have enacted
confidentiality statutes that incorporate federal provisions, "[o]ther states have
confidentiality provisions that do not rely on federal law").
192 See Order Denying Motion to Compel, supra note 144, at 8; see also supra notes 180-
82 and accompanying text.
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The second issue is whether the court was correct in determining that
the Florida legislature's enactment of a statute authorizing drug courts
reflected a policy determination to draw a distinction between drug-related
and other offenses, whereby drug-related offenses committed during court-
supervised treatment are viewed not as new crimes, but as part of the
original crime that put the treatment participant in the drug court
program. 193 While the court made this point in relation to its decision to
deny that the state had shown good cause under § 42 U.S.C. 290dd-
2(b)(2)(C), the court could have conceivably used this supposed intent as a
basis to rule that Florida's drug court statute pre-empted general statutes
criminalizing drug use. The court's reading of the legislative intent is
undercut by the universal state practice of prosecuting drug court
participants for new rearrests, though. 194  While the court correctly
perceived that state ability to investigate and prosecute relapse-related drug
use through discovery of residential treatment records could threaten the
future of drug courts,' 95 it was incorrect to believe that either the Florida
legislature or Congress had addressed this problem. This part of the
Comment argues that, because there is no legal basis for the de facto, and
necessary, immunity of drug court participants undergoing residential
treatment, states should amend statutes enabling drug courts to explicitly
provide for such immunity.
A. DOES 42 U.S.C. § 290DD-2 SHIELD DRUG COURT PARTICIPANTS?
The issue of whether 42 U.S.C. § 290dd-2 requires law enforcement
officials to obtain a court order for release of patient records concerning
patient drug use on the premises of a treatment program is significantly
more problematic than the Ninth Judicial Circuit's opinion would imply.
As the legislative history indicates, the statute and its implementing
regulations were undoubtedly intended to create broad privacy rights for
individuals in drug treatment; 196 they cannot, however, reasonably be read
193 See Order Denying Motion to Compel, supra note 144, at 9; supra note 189 and
accompanying text.
194 See 2000 DRUG COURT SURVEY REPORT, PART I, supra note 67 and accompanying
text.
195 See Order Denying Motion to Compel, supra note 144, at 10.
If the Court were to grant State's motion in -this case, then all patients who suffer relapses could
be hauled out of treatment programs and into criminal courts on the whim of a state prosecutor or
police officer responding to calls from fellow patients whose motives for reporting the "crimes"
might be questionable. That would destroy the drug court program.
Id.
196 See supra notes 151-52 and accompanying text.
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to contain the broad insulation from the criminal justice system that the
court found in them.
The court was correct to conclude initially that employee observation
of Bush's drug use was a record protected by § 290dd-2.197 As 42 C.F.R. §
2.11 makes clear, "records" refer to any information, whether recorded or
not, that was received or acquired by a federally assisted alcohol or drug
program, and that related to the treatment of that patient's drug abuse, or to
the management and care of that patient.'98 Information regarding relapse-
related drug possession is clearly related both to the treatment of drug
abuse, and the management of the offending patient.
The court erred in its conception of the relationship between § 290dd-
2(b)(2)(C)'s good cause requirement and § 2.12(c)'s exception of
communications regarding on-premise patient crimes from disclosure and
use restrictions, though. Section 290dd-2(c) mandates that a patient record
may not be used to conduct a criminal investigation of a patient unless
released pursuant to a court order issuing on a showing of good cause.' 99
The sole statutory criterion for making this determination is that courts
balance "the public interest and the need for disclosure against the injury to
the patient, to the physician-patient relationship, and to the treatment
services. 2 °°
Part 2.12(c)'s exemption of disclosure and use prohibitions for
communications from treatment providers to law enforcement officials
must be read against the backdrop of the good cause exception in § 290dd-
2(b)(2)(C). If § 2.12(c) is not read as providing that "a patient's
commission of a crime on the premises of the program or against program
personnel or to a threat to commit such a crime ' '  represents a
circumstance in which the balancing test of § 290dd-2(b)(2)(C) is satisfied
irrebuttably, then it is a practical nullity.
Take, for example, the case of a program employee who witnesses a
patient vandalizing the employee's car. Under § 290dd-2(b)(2)(C) and §
2.65(d)(1) alone, a court could not find good cause to disclose information
regarding the incident. According to § 2.65(d)(1), a court shall not find
good cause to revoke confidentiality for patient records unless the crime is
197 See supra note 181.
8 See 42 C.F.R. § 2.11 (2002).
199 42 U.S.C. § 290dd-2(c) (2002) ("Except as authorized by a court order granted under
subsection (b)(2)(C), no record referred to in subsection (a) may be used to initiate or
substantiate any criminal charges against a patient or to conduct any investigation of a
patient.").
200 Id. § 290dd-2(b)(2)(C).
201 42 C.F.R. § 2.12(c) (2002).
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one that is "extremely serious, such as one which causes or directly
threatens loss of life or serious bodily injury including homicide, rape,
kidnapping, armed robbery, assault with a deadly weapon, and child abuse
and neglect., 20 2 If § 2.12(c)'s exception for communications regarding
crimes committed on facility grounds is not read as circumventing the good
cause requirement, then treatment facility could report the incident to
police, but the police would be unable to open an investigation or file
charges.
Section 2.12(c) must be read as authorizing circumvention of the good
cause requirement, then, if it is not to be a practical nullity. At first blush,
this circumvention is flatly inconsistent with § 290-dd2(c)'s requirement
that only records disclosed by court order pursuant to a showing of good
cause may be used to instigate criminal investigations or prosecutions; for §
2.12(c) to be meaningful, it must be construed to permit disclosure in
absence of court order.
This inconsistency is explicable, though, when § 2.12(c) is viewed in
the context of § 290dd-2(b)(2)(C)'s purpose. By requiring a court to find
good cause, the statute is requiring an adjudicator to weigh "the public
interest and the need for disclosure against the injury to the patient, to the
physician-patient relationship, and to the treatment services.""2 3  Section
2.12(c) fleshes out the good-cause balancing test and establishes that
disclosure of information regarding crimes committed on facility property
disclosed in a communication "from program personnel to law enforcement
officers" will always be deemed to satisfy the test. The regulation renders
unnecessary adjudication of whether there is good cause to release
information concerning crimes committed on facility premises by providing
that there will always be good cause to release this information. Given the
reality that program personnel may need to quickly release information
about such crimes to police in emergency situations, the regulation's
interpretation of the good-cause balancing test is not unreasonable.
Moreover, even in an emergency situation, a court may still issue an order
confirming good cause at an early stage of the criminal process-at the time
of arraignment, for example, when charges are initiated against the patient.
The Ninth Judicial Circuit made much of § 2.12(c)'s requirement that
information be disclosed in a communication "from program personnel to
law enforcement officials," concluding that:
[I]t is evident that Regulation 2.12 is designed to allow a facility to report to the police
that a non-drug-related crime has been committed on its premises without fear of
202 Id. § 2.65(d)(1).
203 42 U.S.C. § 290-dd2(b)(2)(C) (2002).
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being penalized for violating patient confidentiality. It is certainly not intended to
compel center employees to talk to police officers.
2 4
While § 2.3(b)'s mandate that the regulations never compel disclosure
undoubtedly supports the court's conclusion that § 2.12(c) was not intended
to force treatment personnel to talk to police, the court's reading of §
2.12(c) as applying only to communications initiated by employees is
unconvincing.
Assuming arguendo that the court's reading of "communications from
treatment personnel to law enforcement officials" as referring only to
communications initiated by employees is one reasonable construction, the
court did not explain why the regulation could not also be construed to refer
to all communications of information held by employees to law
enforcement personnel. After all, any communication, however compelled,
must be directedfrom the holder to the recipient.
This second reading is more plausible because compelled disclosures
of patient information actually pose less of a threat to the values protected
by § 290dd-2(b)(2)(C)'s balancing test than voluntary ones. Even the
court's narrow reading concedes that § 2.12(c) permits treatment personnel
to voluntarily disclose information regarding a crime committed on facility
property. Section 2.12(c), then, must implicitly provide that voluntary
disclosure of information related to crimes on facility property irrebuttably
meets the good cause requirement. Thus, under the balancing test,
disclosure should be permissible in any situation where the public interest is
as strong and the harm is as minimal as in situations governed by § 2.12(c).
Section 2.12(c) should be construed to refer to compelled disclosures
as well as voluntary disclosures, because compelled disclosures are less
harmful to the interests protected by § 290dd-2(a)'s balancing test than are
voluntary disclosures. In both cases, the weight of the public interest-the
detection and punishment of crime-will be identical. In both cases, the
harm to the patient will be the same, and his criminal activities will be
revealed to the state. In the case of voluntary disclosures, the harm to the
physician-patient relationship and to the treatment services might actually
be more severe than in the case of compelled disclosure. Voluntary
disclosure could cause patients to doubt whether treatment personnel could
be trusted with confidential information. Given that the allowance of
compelled disclosures is consistent with both § 2.12(c)'s plain language and
purpose of circumventing good cause hearings for disclosures that are
clearly in the public interest, § 2.12(c) is most reasonably read to allow
204 Order Denying Motion to Compel, supra note 144, at 8; see discussion supra note
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communications from treatment personnel to law enforcement officials
regardless of motivation.
One counter-argument to this position might be that, in the case of
non-violent drug offenses, the public interest in detecting and punishing
crime might be outweighed by the damages to a treatment process in which
relapse is expected.20 5  The Department of Health and Human Services,
anticipating that drug treatment facilities would not likely report drug-
related offenses to police, propounded § 2.12(c) in order, as the court
believed, "to allow a facility to report to the police that a non-drug-related
crime has been committed on its premises without fear of being penalized
for violating patient confidentiality.
2 10 6
This argument is not convincing because it proves too much. While
such a reading might justifiably insulate treatment participants from arrests
on drug charges, it would also prevent compelled disclosures of information
regarding every other species of non-serious crime on facility property. As
discussed above, compelled disclosures of these crimes fare just as well, if
not better, under § 290dd-2(b)(2)(C)'s balancing test, than voluntary
disclosures do. This reading would foreclose them completely, because the
only other regulation permitting compelled disclosures, § 2.65, limits these
disclosures to information involving "extremely serious crimes, such as one
which causes or directly threatens loss of life or serious bodily injury.2Q07
The results would be absurd: treatment personnel would be given,
essentially, the discretion to choose whether or not to prosecute all offenses
that do not fall under 42 C.F.R. § 2.61's "extremely serious crime"
requirement-a list that could include crimes such as theft, assault, battery,
prostitution, or, depending on the court making the good cause
determination, drug trafficking.208
This argument is also undercut by the fact that § 2.12(c) refers to
information "directly related to a patient's commission of' any "crime on
the premises of the program., 20 9 Crucial to the premise of the counter-
argument is the idea that prosecution of drug offenses inflicts a special
harm on the treatment process. If the Department of Health and Human
205 See, e.g., Dorf& Sabel, supra note 2, at 841 ("There [is] unlikely to be a straight path
from addiction to recovery; rather, addicts undertaking recovery could be expected to relapse
into addiction, often many times ... ").
206 Order Denying Motion to Compel, supra note 144, at 8; see discussion supra note
148.
207 42 C.F.R. § 2.65 (2002).
208 According to the notes accompanying the 1987 amendments to enabling regulations,
drug trafficking may or may not necessarily be considered an "extremely serious crime,"
depending on the circumstances. See supra notes 170-74.
209 42 C.F.R. § 2.12(c) (2002).
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Services viewed drug-related offenses as especially threatening to the goals
of treatment, it is unclear why it promulgated a rule that placed no
restrictions on the types of crimes that treatment facilities could report to
authorities. While the agency might have anticipated that treatment
facilities would not disclose information regarding patient drug use, the
regulation in no way prevents them from doing so.
The Ninth Judicial Circuit wrongly held that § 2.12(c) applied only to
disclosures of patient crimes initiated by treatment personnel; information
regarding Bush's alleged possession of crack should have been disclosed to
police when treatment center employees were issued an investigative
subpoena.
B. THE CONSEQUENCES OF THE UNCERTAIN LEGAL STATUS OF DRUG
COURT PARTICIPANTS UNDERGOING RESIDENTIAL TREATMENT
As the above discussion demonstrates, § 290dd-2 does not provide an
adequate legal basis for the immunity of drug court participants undergoing
residential treatment from prosecution on new drug charges. Because state
statutes authorizing drug courts do not provide for such immunity, either,21°
the de facto immunity from prosecution that participants undergoing
residential treatment currently enjoy 21' has no legal basis. Because this
uncertain status of drug court participants poses a threat to the continued
vitality of the drug court sanctioning regime, and yields vastly different
results in the treatment of similarly-situated drug offenders, states should
amend their statutes enabling drug courts to explicitly state that participants
in residential treatment are immune from prosecution for relapse-related
drug offenses.
The uncertain legal status of participants undergoing residential
treatment threatens the continued vitality of drug courts because of the
unique nature of residential treatment. In drug court systems, residential
treatment is often reserved for participants with the most intransigent
addictive behaviors. Residential treatment is regarded as a much more
invasive therapy than outpatient regimes because it involves "constant
supervision" of the offender.213
This constant supervision results in a greater assemblage of evidence
that could be used to prosecute a participant than does outpatient treatment.
210 See supra notes 63-65 and accompanying text.
211 See supra notes 12-13 and accompanying text.
212 See Hora et al., supra note 8, at 511.
213 Id. See also ROBERT L. HUBBARD ET AL., DRUG ABUSE TREATMENT: A NATIONAL
STUDY OF EFFECTIVNESS 56 (1989) ("[Residential] programs are highly structured, with
nearly every moment accounted for.").
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While participants in outpatient treatment must submit urine tests to the
214drug court, positive results from these urine tests alone would not by
themselves provide an adequate evidentiary record for prosecution on a new
drug charge. Under the constant supervision of residential treatment,
however, such a record could be compiled. The constant scrutiny of
treatment personnel can yield direct, and memorialized, observations of
drug possession and uses among patients, as it did in Bush's case.21 5
In residential treatment, moreover, patient drug use is committed, and
dealt with by treatment personnel, in front of other patients. While
treatment personnel might be expected to confine voluntary disclosure of
patient crimes to the drug court,216 treatment patients might not be so
motivated to protect the privacy of other patients. As the Ninth Judicial
Circuit stated:
If the Court were to grant State's motion in this case, then all patients who suffer
relapses could be hauled out of treatment programs and into criminal courts on the
whim of a state prosecutor or police officer responding to calls from fellow patients
whose motives for reporting the "crimes" might be questionable. That would destroy
the drug court program.
While the Ninth Judicial Circuit's conclusion might be exaggerated, the
uncertain status of participants undergoing residential treatment does pose
an under-examined threat to the continuing vitality of drug courts.
This uncertain status also raises an issue about the unacknowledged
disparate treatment of similarly-situated drug offenders. As discussed
above, drug courts have not begun to reach all offenders who meet
eligibility requirements, much less all offenders who might benefit from
drug treatment.218 Insufficient funding and staffing can lead to arbitrary
distinctions being drawn between similarly-situated offenders." 9 One
Department of Justice-sponsored report describes the imposition of
escalating sanctions that awaits offenders that do not qualify for drug
courts:
It is particularly common for defendants on probation for drug offenses to fail to
comply with probation conditions .... Frequently, . . . failure to comply is evidenced
by a new arrest for a drug or drug-related offense . . . which generally results in
imposition of the original sentence suspended when the defendant was placed on
214 Hora et al., supra note 8, at 475.
215 See supra note 140-43 and accompanying text.
216 See supra note 12 and accompanying text.
217 Order Denying Motion to Compel, supra note 144, at 10; see supra note 148 and
accompanying discussion.
21S See supra Part II.B.
219 See supra notes 77-88 and accompanying text.
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probation, and (2) conviction for the new offense, often resulting in an additional
sentence of incarceration. It is common for the cycle to continue indefinitely once the
defendant is released, with an enhanced incarceration sentence imposed each time to
reflect the defendant's lengthening criminal history.
220
Meanwhile, drug court participants undergoing residential treatment enjoy a
de facto immunity from prosecution for further drug offenses.
This Comment does not suggest that the creation of these two groups
of drug offenders raises the possibility of equal protection violations.22'
Nevertheless, the fact that one group of drug offenders is being treated on a
very different model of punishment from another group is suspect given
that the de facto immunity for participants undergoing residential treatment
has been created sub silentio. As discussed above, statutes enabling drug
courts do not provide that drug court sanction schemes were intended to
preempt criminal punishment of further drug use. If state legislatures had
intended the statutes to do so, they should have made their intent explicit,
given that criminal anti-drug laws are active in every state.22  As some
media accounts of Bush's case indicated, the public does not seem to be
aware of the de facto immunity given to some offenders under the drug
court scheme.223 Political recognition that the drug court system allows
some offenders to be treated as patients, while the vast majority of other
offenders are treated as enemies in the war on drugs, would prompt
necessary public debate on the fairness of this scheme.
V. CONCLUSION
In the fifteen year period since the creation of the first drug court, drug
courts have proliferated rapidly and enjoyed a great deal of political
support. In the rush to implement drug courts, however, states and local
jurisdictions have overlooked important aspects of their effect on the rest of
the criminal justice system. Among these is the system's enshrinement of a
rehabilitative model of punishment for drug court participants undergoing
220 U.S. DEP'T OF JUSTICE, LOOKING AT A DECADE OF DRUG COURTS, DRUG COURT
CLEARINGHOUSE AND TECHNICAL ASSISTANCE PROJECT 4 (1998).
221 In all drug courts, either the prosecutor or drug court judge holds plenary authority to
exclude particular offenders. See, e.g., FLA. STAT. ch. 948.08 (2002). Thus, in the absence
of evidence of discrimination against a suspect class, the state could argue that its exclusion
of a particular offender is rationally related to the state objective of selecting only those
offenders whom it determines would be able to benefit from treatment.
222 See supra note 1 and accompanying text.
223 As one commentator wrote, "[T]he rich and powerful are judged by a very different
set of rules [than most drug offenders]. That's why the staff at Noelle's rehab center tore up
a sworn statement incriminating Noelle .... " Arianna Huffington, A Crack House Divided,
TEXAS OBSERVER, (Sept. 27, 2002), at http://www.texasobserver.org/
showArticle.?asp?ArticlelD=1099 (last visited Nov. 5, 2003).
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residential treatment. This class of drug offenders is given the opportunity
to avoid prosecution for relapse-related episodes, in contrast to the many
other offenders who have each relapse-related episode treated as a new
crime. This immunity is necessitated by the drug court sanctioning scheme,
yet state legislatures have not faced the political consequences of mandating
rehabilitative treatment for some drug offenders, and punitive treatment for
others.
This dilemma is one caused by half-measures. As one commentator
has written, American drug policy has historically "vacillated in a
pendulum-like manner between viewing drug abuse as a public safety
concern requiring a punitive correctional response or as a public health
concern requiring a treatment-oriented response. 2 24  The rehabilitative
orientation of drug courts is not likely to be the last word in America's
shifting relationship with drug use. Yet if state governments are to cast
their weight behind rehabilitative efforts, as they have with drug courts,
they should be expected to do so openly, and with due consideration of the
effect on all illegal drug users within their jurisdictions.
224 Douglas B. Marlowe, Effective Strategies for Intervening with Drug Abusing
Offenders, 47 VILL. L. REV. 989,990 (2002).
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